Landiolol

Landiolol

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	IV
ATC code	C07AB14 (WHO)
Legal status
Legal status	℞ (Prescription only)
Identifiers
IUPAC name [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate
CAS Number	133242-30-5 Y
PubChem (CID)	114905
ChemSpider	102855 N
UNII	62NWQ924LH Y
KEGG	D01847 N
Chemical and physical data
Formula	C25H39N3O8
Molar mass	509.59 g/mol
3D model (Jmol)	Interactive image
SMILES CC1(OCC(O1)COC(=O)CCC2=CC=C(C=C2)OCC(CNCCNC(=O)N3CCOCC3)O)C
InChI InChI=1S/C25H39N3O8/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31)/t20-,22+/m0/s1 N Key:WMDSZGFJQKSLLH-RBBKRZOGSA-N N
NY (what is this?)  (verify)

Landiolol (INN) is a drug which acts as a highly cardioselective, ultra short-acting beta blocker. It is used as an antiarrhythmic agent.

References

• Yoshiya I (December 1998). "[Landiolol hydrochloride, a new sympathetic beta blocker]". Masui (in Japanese). 47 Suppl: S126–32. PMID 9921175. 
• Ogata J, Okamoto T, Minami K (2003). "Landiolol for the treatment of tachyarrhythmia associated with atrial fibrillation". Can J Anaesth. 50 (7): 753. doi:10.1007/BF03018726. PMID 12944459.